PROF · Profound Medical Corp. · Executive Compensation
Market Cap
$210.43M
Shares
36.53M
Volume · Sep 30
106.88K
Avg daily vol (3M)
118.74K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard R. Fabian | President | Appointed | 2026-09-03 |
| Rashed Dewan | Chief Financial Officer | Resigned | 2026-08-17 |
| Matthew Sobczyk | Interim Chief Financial Officer | Appointed | 2026-08-17 |
| Frank Baylis | director | Appointed | 2026-03-10 |
| Kris Shah | Board | Resigned | 2026-03-10 |